<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font25 { font-size : 25; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font25">and </span>
   <span class="font16">with </span>
   <span class="font14">were </span>
   <span class="font13">for </span>
   <span class="font13">{background </span>
   <span class="font13">&amp;gt; </span>
   <span class="font13">was </span>
   <span class="font12">compounds </span>
   <span class="font12">cells </span>
   <span class="font12">trVLP </span>
   <span class="font12">viral </span>
   <span class="font12">The </span>
   <span class="font12">antiviral </span>
   <span class="font12">from </span>
   <span class="font12">using </span>
   <span class="font12">virus </span>
   <span class="font12">margin </span>
   <span class="font12">Ebola </span>
   <span class="font12">{border-style </span>
   <span class="font12">RNA </span>
   <span class="font12">px;} </span>
   <span class="font12">receptor </span>
   <span class="font12">#ffffff;} </span>
   <span class="font11">(). </span>
   <span class="font11">activity </span>
   <span class="font11">ibutamoren </span>
   <span class="font11">that </span>
   <span class="font11">HEKT </span>
   <span class="font11">anti-EBOV </span>
   <span class="font11">raloxifene </span>
   <span class="font11">(Fig. </span>
   <span class="font11">FLuc </span>
   <span class="font11">VP, </span>
   <span class="font11">analysis </span>
   <span class="font11">cell </span>
   <span class="font11">chemical </span>
   <span class="font11">luciferase </span>
   <span class="font11">tetracistronic </span>
   <span class="font11">values </span>
   <span class="font11">well </span>
   <span class="font10">EBOV </span>
   <span class="font10">Korea </span>
   <span class="font10">against </span>
   <span class="font10">antagonist </span>
   <span class="font10">are </span>
   <span class="font10">into </span>
   <span class="font10">minigenome </span>
   <span class="font10">protein </span>
   <span class="font10">proteins </span>
   <span class="font10">px; </span>
   <span class="font10">sertindole, </span>
   <span class="font10">{font-family </span>
   <span class="font10">-VP </span>
   <span class="font10">RLuc </span>
   <span class="font10">antibody </span>
   <span class="font10">assay </span>
   <span class="font10">concentration </span>
   <span class="font10">concentrations </span>
   <span class="font10">day </span>
   <span class="font10">font-size </span>
   <span class="font10">hit </span>
   <span class="font10">infected </span>
   <span class="font10">per </span>
   <span class="font10">performed </span>
   <span class="font10">replication </span>
   <span class="font10">screening </span>
   <span class="font10">system </span>
   <span class="font10">transfected </span>
   <span class="font10">which </span>
   <span class="font10">Fig. </span>
   <span class="font10">culture </span>
   <span class="font10">double; </span>
   <span class="font10">each </span>
   <span class="font10">infection </span>
   <span class="font10">its </span>
   <span class="font10">life </span>
   <span class="font10">ng), </span>
   <span class="font10">particle </span>
   <span class="font10">progeny </span>
   <span class="font10">their </span>
   <span class="font10">this </span>
   <span class="font10">trVLPs </span>
   <span class="font10">via </span>
   <span class="font10">virus-like </span>
   <span class="font10">&amp;lt; </span>
   <span class="font10">RBV </span>
   <span class="font10">Virol./JVI.- </span>
   <span class="font10">active </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cytotoxicity </span>
   <span class="font10">expression </span>
   <span class="font10">generation </span>
   <span class="font10">hormone </span>
   <span class="font10">including </span>
   <span class="font10">increasing </span>
   <span class="font10">inhibition </span>
   <span class="font10">library </span>
   <span class="font10">polymerase </span>
   <span class="font10">presence </span>
   <span class="font10">purified </span>
   <span class="font10">sertindole </span>
   <span class="font10">solid; </span>
   <span class="font10">specific </span>
   <span class="font10">under </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">Î¼g), </span>
   <span class="font10">(-). </span>
   <span class="font10">(Cat. </span>
   <span class="font10">(P) </span>
   <span class="font10">(by </span>
   <span class="font10">-well </span>
   <span class="font10">Confocal </span>
   <span class="font10">Dopamine </span>
   <span class="font10">GHSR </span>
   <span class="font10">Histamine </span>
   <span class="font10">PCR </span>
   <span class="font10">These </span>
   <span class="font10">This </span>
   <span class="font10">agonist </span>
   <span class="font10">average </span>
   <span class="font10">bold </span>
   <span class="font10">chemicals </span>
   <span class="font10">compound </span>
   <span class="font10">compounds. </span>
   <span class="font10">control. </span>
   <span class="font10">courier; </span>
   <span class="font10">cytotoxic </span>
   <span class="font10">derivatives </span>
   <span class="font10">derived </span>
   <span class="font10">dual </span>
   <span class="font10">em; </span>
   <span class="font10">entry </span>
   <span class="font10">group </span>
   <span class="font10">growth </span>
   <span class="font10">harvested </span>
   <span class="font10">have </span>
   <span class="font10">inhibitor </span>
   <span class="font10">inhibitory </span>
   <span class="font10">level </span>
   <span class="font10">levels </span>
   <span class="font10">no. </span>
   <span class="font10">not </span>
   <span class="font10">other </span>
   <span class="font10">p.i., </span>
   <span class="font10">plates </span>
   <span class="font10">primer </span>
   <span class="font10">protein-coupled </span>
   <span class="font10">pt;} </span>
   <span class="font10">purchased </span>
   <span class="font10">raloxifene, </span>
   <span class="font10">ratio </span>
   <span class="font10">replication-competent </span>
   <span class="font10">reporter </span>
   <span class="font10">revealed </span>
   <span class="font10">secretagogue </span>
   <span class="font10">selected </span>
   <span class="font10">set </span>
   <span class="font10">showed </span>
   <span class="font10">spots </span>
   <span class="font10">supernatants </span>
   <span class="font10">target </span>
   <span class="font10">these </span>
   <span class="font10">three </span>
   <span class="font10">transcription </span>
   <span class="font10">viability </span>
  </p>
 </body>
</html>
